- Home
- ZVSA vs UOKA Comparison
ZVSA vs UOKA Comparison
Compare ZVSA & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- UOKA
- Stock Information
- Founded
- ZVSA 2014
- UOKA 2002
- Country
- ZVSA United States
- UOKA United Kingdom
- Employees
- ZVSA N/A
- UOKA N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- ZVSA Health Care
- UOKA
- Exchange
- ZVSA Nasdaq
- UOKA NYSE
- Market Cap
- ZVSA 3.0M
- UOKA 2.7M
- IPO Year
- ZVSA N/A
- UOKA N/A
- Fundamental
- Price
- ZVSA $0.69
- UOKA $2.40
- Analyst Decision
- ZVSA
- UOKA
- Analyst Count
- ZVSA 0
- UOKA 0
- Target Price
- ZVSA N/A
- UOKA N/A
- AVG Volume (30 Days)
- ZVSA 1.5M
- UOKA 128.0K
- Earning Date
- ZVSA 08-08-2025
- UOKA 08-16-2025
- Dividend Yield
- ZVSA N/A
- UOKA N/A
- EPS Growth
- ZVSA N/A
- UOKA N/A
- EPS
- ZVSA N/A
- UOKA N/A
- Revenue
- ZVSA N/A
- UOKA $48,375.00
- Revenue This Year
- ZVSA N/A
- UOKA N/A
- Revenue Next Year
- ZVSA N/A
- UOKA N/A
- P/E Ratio
- ZVSA N/A
- UOKA N/A
- Revenue Growth
- ZVSA N/A
- UOKA N/A
- 52 Week Low
- ZVSA $0.47
- UOKA $1.98
- 52 Week High
- ZVSA $6.30
- UOKA $42.50
- Technical
- Relative Strength Index (RSI)
- ZVSA 53.43
- UOKA N/A
- Support Level
- ZVSA $0.61
- UOKA N/A
- Resistance Level
- ZVSA $0.73
- UOKA N/A
- Average True Range (ATR)
- ZVSA 0.07
- UOKA 0.00
- MACD
- ZVSA 0.00
- UOKA 0.00
- Stochastic Oscillator
- ZVSA 36.53
- UOKA 0.00
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About UOKA MDJM LTD
MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.